Division of Hematology & Thromboembolism

Mark Crowther

MD, MSc, FRCPC

Professor and Chair, Department of Medicine

Professor (Associate Member), Department of Pathology and Molecular Medicine

Professor (Associate), Department of Health Research Methods, Evidence and Impact

Leo Pharma Chair in Thromboembolism Research, McMaster University

 

 

Education and Professional Standing

MD, University of Western Ontario, 1990
FRCPC Internal Medicine, 1994
FRCPC Hematology, 1995
MSc Health Research Methodology, 1998
Fellow of the Royal Society of Canada (FRSC), 2017

Research Interests

Dr Crowther’s research interests include exploring ways of improving the way that we use our current anticoagulant drugs.  These include exploring established and novel interventions to mitigate bleeding, and studies of currently available anticoagulant drugs in high-risk patient populations. Dr Crowther’s work also focusses on developing systematic reviews of key questions in Hematology and Thrombosis, and basing Guidelines on those reviews.

Dr Crowther has more than 400 peer reviewed publications, was inducted into the Royal Society of Canada in 2017, and received the 2017 International Society of Thrombosis and Haemostasis BACH Investigator Recognition Award. He was one of 14 scientists from the Michael G. DeGroote School of Medicine at McMaster University cited by Clarivate Analytics on its Highly Cited Researchers list (formerly known as Thomson Reuter's annual publication of The World's Most Influential Scientific Minds).

Dr Crowther is currently the Chair, Department of Medicine at McMaster University and holds the Leo Pharma Chair in Thromboembolism Research at McMaster University.

Selected Publications

View Dr Crowther's PubMed Listings here